Amdocs Ltd logo

Amdocs Ltd

NEW
NAS:DOX (USA)  
$ 60.27 +0.48 (+0.8%) 10:08 PM EST
14.35
P/B:
1.91
Market Cap:
$ 6.29B
Enterprise V:
$ 7.21B
Volume:
958.63K
Avg Vol (2M):
1.22M
Trade In:
Volume:
958.63K
Avg Vol (2M):
1.22M

Business Description

Amdocs Ltd logo
Amdocs Ltd
NAICS : 541519 SIC : 7379
ISIN : GB0022569080

Total Employee Number:

26,969
Description
Amdocs Ltd is a provider of software and services to communications, entertainment, and media service providers. The Company operates in a single segment and designs, develops, markets, supports, implements, and operates open and modular cloud offerings. Its portfolio includes solutions across digital business systems and legacy business and operational support systems, supporting multiple lines of business such as wireless, broadband, cable, fiber, satellite, and digital services. The Company leverages artificial intelligence to support digital transformation, cloud adoption, and intelligent network automation. Geographically, it derives a majority of its revenue from North America and also operates in Europe and the rest of the world.
Name Current Vs Industry Vs History
Cash-To-Debt
0.19
Equity-to-Asset
0.51
Debt-to-Equity
0.33
Debt-to-EBITDA
1.29
Interest Coverage
17.57
Piotroski F-Score
7/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score
2.24
Distress
Grey
Safe
Beneish M-Score
-2.55
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI
33.85
9-Day RSI
44.99
14-Day RSI
51.56
3-1 Month Momentum %
2.84
6-1 Month Momentum %
-13.66
12-1 Month Momentum %
-30.16

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio
0.94
Quick Ratio
0.94
Cash Ratio
0.12
Days Sales Outstanding
69.92
Days Payable
69.66

Dividend & Buy Back

Name Current Vs Industry Vs History
Dividend Yield %
3.61
Dividend Payout Ratio
0.31
3-Year Dividend Growth Rate
10.1
Forward Dividend Yield %
3.75
5-Year Yield-on-Cost %
5.84
3-Year Average Share Buyback Ratio
3.5
Shareholder Yield %
9.82

Financials (Next Earnings Date:2026-11-11 Est.)

DOX's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Amdocs Ltd Operating Data

DOX's Complete Operating Data
No operating data available for Amdocs Ltd.

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:DOX

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017

Amdocs Ltd Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 4,653.031
EPS (TTM) ($) 4.2
Beta 0.3914
3-Year Sharpe Ratio -0.59
3-Year Sortino Ratio -0.71
Volatility % 32.95
14-Day RSI 51.56
14-Day ATR ($) 1.579409
20-Day SMA ($) 61.0225
12-1 Month Momentum % -30.16
52-Week Range ($) 49.74 - 85.66
Shares Outstanding (Mil) 104.42

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 7
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Amdocs Ltd Filings

Filing Date Document Date Form
No Filing Data

Amdocs Ltd Stock Events

Financials Calendars
Event Date Price ($)
First quarter earnings conference call for 2027 2027-02-03 17:00 In 146 days
First quarter earnings results for 2027 2027-02-03 In 145 days
General meeting for 2026 2027-01-29 11:00 In 141 days
Annual report for 2026 2026-12-15 In 95 days
Fourth quarter earnings conference call for 2026 2026-11-11 17:00 In 62 days
Fourth quarter earnings results for 2026 2026-11-11 In 61 days
USD 0.569000 Cash Dividend 2026-09-30 In 19 days
Piper Sandler Growth Frontiers Conference 2026-09-15 In 4 days
Wolfe Research TMT Conference 2026-09-10 59.81 (-0.27%)
Guidance call for 2026 2026-09-09 13:15 59.97 (-2.67%)
Show
Entries

Amdocs Ltd Frequently Asked Questions

What is Amdocs Ltd(DOX)'s stock price today?
The current price of DOX is $60.27. The 52 week high of DOX is $85.66 and 52 week low is $49.74.
When is next earnings date of Amdocs Ltd(DOX)?
The next earnings date of Amdocs Ltd(DOX) is 2026-11-11 Est..
Does Amdocs Ltd(DOX) pay dividends? If so, how much?
The  Dividend Yield %  of Amdocs Ltd(DOX) is 3.61% (As of Today), Highest Dividend Payout Ratio of Amdocs Ltd(DOX) was 0.31. The lowest was 0.21. And the median was 0.29. The  Forward Dividend Yield % of Amdocs Ltd(DOX) is 3.75%. For more information regarding to dividend, please check our Dividend Page.

Guru Commentaries on NAS:DOX

2026 Q2
ef2f99 d96bdc35121943fa8d56dc659e27d164
What the manager wrote

Amdocs has been negatively impacted as it is perceived as a casualty of artificial intelligence. The company operates a hybrid model with two-thirds of revenue from managed services and one-third from systems integration/custom software. Its core billing and customer care systems are critical for telecommunications giants, making them less susceptible to quick displacement. However, the stock is trading at a historically low valuation of around 7x free cash flow, which reflects a severe outcome that is not evident in the current business trajectory. While Amdocs may pass along automation benefits to clients, this could constrain revenue growth.

2026 Q2
uc
What the manager wrote

Amdocs Ltd. provides IT services to telecommunication companies as they seek to digitally transform operations and customer service; leading clients include AT&T and T-Mobile. Amdocs posted a solid quarter, with a slight earnings beat and modestly higher guidance. Amdocs has been actively engaged in using AI to enhance its value proposition, including by introducing an agentic operating system designed specifically for the telecom industry. We think this mix of uncertainty is reflected in the stock price, and we maintained our position.

2026 Q2
What the manager wrote

Amdocs was among the largest detractors in our portfolio, reflecting current investor concerns that resemble the skepticism surrounding the transition to cloud computing. While the market views AI as a threat to portions of the IT services industry, we believe many companies, including Amdocs, are well positioned to benefit by helping clients implement and optimize these technologies. However, the recent performance indicates that the market is overly focused on disruption risks, which has negatively impacted Amdocs' valuation.

2026 Q2
What the manager wrote

Amdocs has faced significant challenges as fears surrounding AI's impact on its business model have intensified. The market appears to be misinterpreting the critical nature of Amdocs' services, which are deeply embedded within major companies. Despite this, the stock has declined materially, reflecting concerns that AI may shrink their respective businesses. We believe the market is underestimating the importance of Amdocs' offerings, which could lead to further volatility in its stock price.

2026 Q2
uc
What the manager wrote

Amdocs is mentioned as part of the Fund’s underweight exposure to the information technology sector, which has been a significant detractor from performance. Investor concerns are noted regarding the durability of legacy enterprise software models amid rapid advancements in AI, with Amdocs specifically highlighted as a company in this category. The letter indicates that the market may have excessively discounted the near-term disruption risk for such companies.

2026 Q2
brandes-small-cap-value-fund-2026-q2
What the manager wrote

Amdocs is mentioned as part of the Fund's holdings in the technology sector, which performed poorly due to concerns about the durability of legacy enterprise software models amid rapid AI advancements. The manager notes that the market has excessively discounted the near-term disruption risk for companies like Amdocs, indicating a belief that the current valuation may not reflect the long-term potential.

2026 Q1
What the manager wrote

Amdocs is our largest position and we believe it is far less exposed to AI-driven disruption than many SaaS companies. The company is deeply embedded in systems of record and mission-critical infrastructure for tier-1 telecommunications customers, which results in high switching costs and strong customer retention. Amdocs generates revenue through long-term managed services contracts that often involve substantial customization and integration. While AI may compress some service revenue, Amdocs is proactively incorporating automation and AI into its offerings, focusing on automating infrastructure complexity within regulated telecom ecosystems. The valuation is attractive at approximately 10x free cash flow, the cheapest it has been in years.

2025 Q3
3Q25 PVCMX letter
What the manager wrote

Amdocs, which is one of the Fund’s largest positions, posted a modest share price decline in the period despite continuing to deliver steady gains in operating income. Investors less familiar with the company may be confused by recent decreases in the top line, which stemmed from an intentional disposition of certain no-margin, non-core businesses. Our valuation for Amdocs has increased reliably over the years. Due to the company’s operating stability, excellent balance sheet, and strong competitive position in helping its customers modernize their networks, we assign the shares an above average valuation multiple.

2025 Q1
What the manager wrote

We initiated a position in Amdocs, a provider of software and services to communications and media companies in both developed and emerging markets. Amdocs pays a 2.6% dividend, which is slightly above average in the universe. The company is also buying back shares, which we view positively. Overall, the stock ranks in the top 15% of stocks in our ranking universe, which is within our buy range.

Headlines

See More
  • 1
No news.
  • 1